Enhanced analgesic effects and gastrointestinal safety of a novel, hydrogen sulfide-releasing anti-inflammatory drug (ATB-352): a role for endogenous cannabinoids (2020)
- Authors:
- USP affiliated authors: COSTA, SORAIA KÁTIA PEREIRA - ICB ; MUSCARA, MARCELO NICOLAS - ICB ; DALLAZEN, JORGE LUIZ - ICB
- Unidade: ICB
- DOI: 10.1089/ars.2019.7884
- Subjects: FARMACOLOGIA; ANALGÉSICOS; INFLAMAÇÃO; DOR; ÚLCERA GÁSTRICA; SISTEMA GASTROINTESTINAL; ANTI-INFLAMATÓRIOS NÃO ESTEROIDES; MEDICAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: New Rochelle
- Date published: 2020
- Source:
- Título do periódico: Antioxidants & Redox Signaling
- ISSN: 1557-7716
- Volume/Número/Paginação/Ano: 7 p., 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
COSTA, Soraia Katia Pereira et al. Enhanced analgesic effects and gastrointestinal safety of a novel, hydrogen sulfide-releasing anti-inflammatory drug (ATB-352): a role for endogenous cannabinoids. Antioxidants & Redox Signaling, p. 7 , 2020Tradução . . Disponível em: https://doi.org/10.1089/ars.2019.7884. Acesso em: 03 jun. 2024. -
APA
Costa, S. K. P., Allain, T., Dallazen, J. L., Santos, L. G., Buret, A. G., Vaughan, D. J., et al. (2020). Enhanced analgesic effects and gastrointestinal safety of a novel, hydrogen sulfide-releasing anti-inflammatory drug (ATB-352): a role for endogenous cannabinoids. Antioxidants & Redox Signaling, 7 . doi:10.1089/ars.2019.7884 -
NLM
Costa SKP, Allain T, Dallazen JL, Santos LG, Buret AG, Vaughan DJ, Fowler CJ, De Nucci G, Wallace JL. Enhanced analgesic effects and gastrointestinal safety of a novel, hydrogen sulfide-releasing anti-inflammatory drug (ATB-352): a role for endogenous cannabinoids [Internet]. Antioxidants & Redox Signaling. 2020 ;7 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1089/ars.2019.7884 -
Vancouver
Costa SKP, Allain T, Dallazen JL, Santos LG, Buret AG, Vaughan DJ, Fowler CJ, De Nucci G, Wallace JL. Enhanced analgesic effects and gastrointestinal safety of a novel, hydrogen sulfide-releasing anti-inflammatory drug (ATB-352): a role for endogenous cannabinoids [Internet]. Antioxidants & Redox Signaling. 2020 ;7 .[citado 2024 jun. 03 ] Available from: https://doi.org/10.1089/ars.2019.7884 - Novel hydrogen sulfide research approach to treat interstitial cystitis/bladder pain: role of gender differences
- Secreção e composição salivar em ratos com doença periodontal
- Alterations in rat brain and diaphragm after intestinal ischemia-reperfusion
- Periodontal disease affects carrageenan-induced temporomandibular joint arthritis in rats
- Establishing a new method to assess hypernociception in phospholipase A2-induced pancreatitis in rats
- PAR2-induced arthritis in the rat temporomandibular joint
- Increased glutathione levels contribute to the beneficial effects of hydrogen sulfide and inducible nitric oxide inhibition in allergic lung inflammation
- Avaliação das atividades cicatrizante, anti-inflamatória tópica e antioxidante do extrato etanólico da Sideroxylon obtusifolium (quixabeira)
- Early-lifetime exposure to 1,2-naphthoquinone (1,2-NQ) interact to increase asthma susceptibility in juvenile mice
- Oxidative changes in diaphragm muscles from rats submitted to intestinal ischemia and reperfusion
Informações sobre o DOI: 10.1089/ars.2019.7884 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
